Two Sigma Securities’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-437
Closed -$12K 2669
2021
Q4
$12K Buy
+437
New +$19K ﹤0.01% 1467

Other funds holding ELOX

Two Sigma Securities's ELOX Position: Q1 2022 in Review

Two Sigma Securities sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2022, closing a stake of 437 shares — an estimated $12K sold.

Two Sigma Securities first reported a position in ELOX in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 35 funds tracked by Wall St. Rank hold ELOX as of Q1 2022.

  • Two Sigma Securities reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Securities sold 437 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $12K.
  • Two Sigma Securities first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Two Sigma Securities's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $12K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Securities's 13F filing for Q1 2022, filed 16 May 2022.